Depression and its associated factors among people who use drugs attending the Methadone Treatment Clinic at Tumbi Hospital in Pwani, Tanzania: A cross-sectional study
Anna Chrispo Charle, Masunga K. Iseselo, Sofia Sanga

TL;DR
This study found that 74% of methadone clinic patients in Tanzania experience depression, with women and those with incarceration histories being especially at risk.
Contribution
The study identifies key risk factors for depression in a methadone treatment population in Tanzania, including gender and incarceration history.
Findings
73.9% of methadone clinic attendees in Tanzania had depression, with 47.9% experiencing minimal depression.
Women were 15 times more likely to have depression than men, and those with incarceration histories had twice the risk.
Lack of social support increased depression risk fivefold, while tramadol use reduced it.
Abstract
Opioid use disorder is a major global health concern. While methadone treatment is effective in treating opioid use disorder, individuals often experience severe mental health issues, particularly depression. This study aimed to assess the prevalence of depression and its associated factors among clients attending a methadone clinic in the Pwani Region, Tanzania. A cross-sectional study was conducted at Tumbi Hospital to assess the prevalence of depression and its associated factors among 261 clients at the methadone treatment clinic. Participants were recruited through simple random sampling. Depression-related data were collected using the Patient Health Questionnaire-9 (PHQ-9). Descriptive statistics were used to analyze the socio-demographic and clinical data and prevalence of depression. Furthermore, bivariate and multivariate logistic regression were used to determine the factors…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSubstance Abuse Treatment and Outcomes · Opioid Use Disorder Treatment · HIV, Drug Use, Sexual Risk
